Interim analysis of the real-world CHOPIN study shows reduction in HAE attacks and improvement in PROs with lanadelumab

Navigating the spectrum of food refusal in children with IgE-mediated and non-IgE-mediated allergies

Symptom reduction and QoL improvement in CRSwNP patients with mepolizumab: Results from the phase 3 SYNAPSE trial

Improving asthma remission with benralizumab in real-world asthma patients in the US: Results from the ZEPHYR-4 study

The role of TRP channels in the pathophysiology of nasal hyperreactivity and their potential as a treatment target

Determining the diagnostic vital sign parameters in pediatric oral food challenges: Results from a US-based retrospective study

Impact of high-fat diet on skin microbiome in pediatric patients with food allergies and eczema

Identifying high-risk infants for AD through early skin microbiome and metabolome signatures: A sub-cohort analysis of the S-PRESTO study